Table 2 Diagnostic performance in BPH/LUTS patients undergoing a biopsy or multiple biopsies.

From: Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia

Model

AUC

Sensitivity

Specificity

PPV

NPV

OR

(CI)

Biopsy

0.75

0.9

0.45

0.72

0.74

7.4

(4.9,11)*

Multiple biopsy

0.87

0.9

0.67

0.93

0.58

18.7

(10.8,33)*

  1. Diagnostic performance (AUC), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), odds ratio (OR), and 95% confidence interval (CI) of the OR for each model. *p < 0.05 in discrimination accuracy.
Back to article page